Sanofi
SNY
| News
| $47.99
|
|
Health Technology
(0.0% 1d) (-6.5% 1m) (-3.5% 1y) (0.0% 2d) (1.2% 3d) (1.1% 7d) (Infinity% volume)
http://www.sanofi.com
Sec Filling | Patents | 100409 employees
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
add to today's watch list email alert is off
vaccine cardiovascular diabetes diabetic
Press-releases
New England Journal of Medicine publishes positive Phase 3 Dupixent® (dupilumab) results in children with moderate-to-severe asthma
Published: 2021-12-08 (Crawled : 23:00) - globenewswire.com
SNYNF | News | $93.73 |
|
Health Technology
REGN | News | $654.04 |
|
Health Technology
SNY | News | $47.99 |
|
Health Technology
TEVJF | News | $9.388 |
|
Health Technology
dupixent era positive results children phase 3
BioNTech to Hold Digital Press Conference to Provide an Update on Omicron Variant
Published: 2021-12-08 (Crawled : 12:30) - globenewswire.com
SNY | News | $47.99 |
|
Health Technology
|
| O: 1.5%
H: 0.09%
C: -0.33%
SNYNF | News | $93.73 |
|
Health Technology
|
| O: -2.14%
H: 0.34%
C: 0.34%
BNTX | News | $308.95 |
|
Health Technology
|
| O: 7.25%
H: 0.0%
C: 0.0%
conference
Pfizer and BioNTech Provide Update on Omicron Variant
Published: 2021-12-08 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $93.73 |
|
Health Technology
|
| O: -2.14%
H: 0.34%
C: 0.34%
BNTX | News | $308.95 |
|
Health Technology
|
| O: 7.25%
H: 0.0%
C: 0.0%
SNY | News | $47.99 |
|
Health Technology
|
| O: 1.5%
H: 0.09%
C: -0.33%
PFE | News | $51.4 |
|
Health Technology
|
| O: 2.41%
H: 0.63%
C: -2.56%
Global HIV-1 Market and Epidemiology Overview 2018-2030 with Insights Into Marketed & Emerging Drugs from Merck Sharp & Dohme, Gilead Sciences, and ViiV Healthcare
Published: 2021-12-08 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $93.73 |
|
Health Technology
|
| O: -2.14%
H: 0.34%
C: 0.34%
GILD | News | $69.71 |
|
Health Technology
|
| O: 0.72%
H: 0.82%
C: -0.29%
THTX | News | $3.24 |
|
Health Technology
|
| O: 0.62%
H: 0.0%
C: 0.0%
SNY | News | $47.99 |
|
Health Technology
|
| O: 1.5%
H: 0.09%
C: -0.33%
thc drug hiv
Johnston & Murphy Levels Up Workplace Communications With YOOBIC's Digital Solution
Published: 2021-12-07 (Crawled : 15:00) - prnewswire.com
GCO | $64.72 |
|
Distribution Services
|
| O: 2.66%
H: 3.55%
C: -0.06%
SNY | News | $47.99 |
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
SNYNF | News | $93.73 |
|
Health Technology
|
| O: 3.63%
H: 0.0%
C: 0.0%
communication communications
Preclinical Studies Demonstrate Sotrovimab Retains Activity Against the Full Combination of Mutations in the Spike Protein of the Omicron SARS-CoV-2 Variant
Published: 2021-12-07 (Crawled : 09:00) - globenewswire.com
SNYNF | News | $93.73 |
|
Health Technology
|
| O: 3.63%
H: 0.0%
C: 0.0%
GSK | News | $42.68 |
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: 0.0%
VIR | $41.89 |
|
Health Technology
|
| O: -6.42%
H: 8.6%
C: 8.45%
GLAXF | News | $20.5305 |
|
Health Technology
|
| O: 5.22%
H: 0.0%
C: -1.25%
XNCR | $35.8 |
|
Health Technology
|
| O: -2.12%
H: 4.74%
C: 2.8%
SNY | News | $47.99 |
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
preclinical sars-cov-2
Baidu Announces Results of Extraordinary General Meeting
Published: 2021-12-07 (Crawled : 09:00) - prnewswire.com
SNY | News | $47.99 |
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
BIDU | $148.93 |
|
Technology Services
|
| O: 10.27%
H: 0.95%
C: -0.19%
SNYNF | News | $93.73 |
|
Health Technology
|
| O: 3.63%
H: 0.0%
C: 0.0%
era results
Ventus Therapeutics Appoints Three New Members to Board of Directors
Published: 2021-12-07 (Crawled : 14:00) - biospace.com/
SNYNF | News | $93.73 |
|
Health Technology
|
| O: 3.63%
H: 0.0%
C: 0.0%
SESN | $1.08 |
|
Health Technology
|
| O: 7.16%
H: 11.56%
C: 9.55%
HBCYF | $5.8176 |
|
Finance
|
| O: 1.74%
H: 0.98%
C: 0.17%
SNY | News | $47.99 |
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
ISEE | $14.79 |
|
Health Technology
|
| O: -1.34%
H: 5.37%
C: 3.58%
AKRO | $21.1 |
|
Health Technology
|
| O: 2.19%
H: 5.76%
C: 3.64%
HSBC | $29.05 |
|
Finance
|
| O: 1.14%
H: 0.75%
C: 0.48%
CM | $112.41 |
|
Finance
|
| O: 1.6%
H: 0.54%
C: 0.26%
era therapeutics
The Global Research Antibodies Market Size is Expected to Reach USD 5.9 Billion by 2028 Expanding at a CAGR of 6.4%
Published: 2021-12-06 (Crawled : 21:00) - prnewswire.com
PKI | News | $190.32 |
|
Health Technology
|
| O: 1.44%
H: 0.0%
C: 0.0%
SNY | News | $47.99 |
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
SNYNF | News | $93.73 |
|
Health Technology
|
| O: 3.63%
H: 0.0%
C: 0.0%
ABCM | $23.11 |
|
Health Technology
|
| O: 3.15%
H: 3.01%
C: 1.06%
research
Reinventing Channel Management: A New Approach for Today’s Digital Environment
Published: 2021-12-06 (Crawled : 19:00) - modeln.com
SNYNF | News | $93.73 |
|
Health Technology
|
| O: 3.63%
H: 0.0%
C: 0.0%
SNY | News | $47.99 |
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
oda
Last 15 days Sec forms
| File Id | Form | Date | Direction | Code | Amount Transacted | Owned Amount |